Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • New Delhi

    Tag: new delhi

    You Searched For "New Delhi"
    Glenmark gets USFDA nod for generic version of acne treatment gel

    Glenmark gets USFDA nod for generic version of acne treatment gel

    Farhat Nasim17 March 2019 9:21 AM IST
    New Delhi: Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for its generic version of BenzaClin gel...
    Unichem Labs gets USFDA nod to market Allopurinol tablets

    Unichem Labs gets USFDA nod to market Allopurinol tablets

    Farhat Nasim15 March 2019 9:35 AM IST
    Allopurinol tablets will be commercialised from company's Ghaziabad plant, Unichem Laboratories said.New Delhi: Drug firm Unichem Laboratories...
    Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar

    Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar

    Farhat Nasim7 March 2019 9:30 AM IST
    Cipla said, its cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg) is generic therapeutic equivalent version of Sensipar, a...
    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Farhat Nasim6 March 2019 9:30 AM IST
    Imatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
    Cipla to acquire 11.71 percent stake in Wellthy Therapeutics

    Cipla to acquire 11.71 percent stake in Wellthy Therapeutics

    Garima20 Feb 2019 2:55 PM IST
    New Delhi: Drug major Cipla Monday said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Golden cross Pharma, a...
    Nestle India to launch nearly three dozen products in 2019, eyes higher exports

    Nestle India to launch nearly three dozen products in 2019, eyes higher exports

    Medical Dialogues Bureau20 Feb 2019 9:30 AM IST
    Nestle, whose 6 per cent revenues come from exports, is now looking to tap more overseas markets by targeting countries with higher Indian diaspora...
    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Farhat Nasim17 Feb 2019 9:30 AM IST
    The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine...
    Eight medical devices including CT, MRI, X-ray notified as DRUGS by health ministry

    Eight medical devices including CT, MRI, X-ray notified as DRUGS by health ministry

    Meghna A Singhania9 Feb 2019 12:04 PM IST
    New Delhi: In a significant move to provide safety to patients and regulate the quality of diagnostic and medical devices in India, the health...
    Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant

    Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant

    Farhat Nasim8 Feb 2019 11:40 AM IST
    Fulvestrant injection is a generic version of AstraZeneca Pharmaceuticals LP's Faslodex injection in the same strength, it added. The Faslodex...
    Fall in customs duty likely on certain medical devices

    Fall in customs duty likely on certain medical devices

    Medical Dialogues Bureau22 Jan 2019 2:04 PM IST
    Industry chamber CII in its has pre-budget memorandum has asked the government to reduce customs duty from 10 per cent to 2.5 per cent on PDS Plates...
    HUL expects to complete merger with GSK Consumer Healthcare in 2019

    HUL expects to complete merger with GSK Consumer Healthcare in 2019

    Medical Dialogues Bureau20 Jan 2019 9:45 AM IST
    "Once we get the court's approval, GSK Consumer India would merge into HUL. That process, we expected to take between 6 to 9 months because we require...
    Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019

    Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019

    Medical Dialogues Bureau17 Jan 2019 9:45 AM IST
    "We are investing Rs 500 crore to add 830 beds in 2019 across our three hospitals. This includes 232 beds in our Panchkula hospital which we have just...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok